Stock 002022 SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Kehua Bio-Engineering Co.,Ltd

Equities

002022

CNE000001KC9

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
7.31 CNY +3.98% Intraday chart for Shanghai Kehua Bio-Engineering Co.,Ltd +7.50% -35.76%
Apr. 28 Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 15 Kehua Bio-Engineering Gets Registration Certificates for Two Devices MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,833 6,010 7,931 7,632 6,362 5,853
Enterprise Value (EV) 1 4,703 6,032 6,890 7,889 3,753 4,813
P/E ratio 23.2 x 29.6 x 11.7 x 10.9 x 6.79 x -25 x
Yield 0.69% 0.56% 1.3% 0.44% 4.85% -
Capitalization / Revenue 2.43 x 2.49 x 1.91 x 1.79 x 0.91 x 2.41 x
EV / Revenue 2.36 x 2.5 x 1.66 x 1.85 x 0.54 x 1.98 x
EV / EBITDA 13.7 x 13.4 x 4.57 x 5.19 x 1.65 x 107 x
EV / FCF 182 x -72.7 x 10.5 x 15.8 x 2.68 x -6.12 x
FCF Yield 0.55% -1.38% 9.48% 6.31% 37.3% -16.3%
Price to Book 2.22 x 2.55 x 2.53 x 2.03 x 1.32 x 1.4 x
Nbr of stocks (in thousands) 515,224 514,527 514,357 514,268 514,297 514,298
Reference price 2 9.380 11.68 15.42 14.84 12.37 11.38
Announcement Date 3/21/19 4/28/20 4/27/21 4/29/22 3/22/23 3/22/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,990 2,414 4,155 4,268 6,970 2,428
EBITDA 1 344.5 450.5 1,509 1,521 2,280 44.92
EBIT 1 259.4 331.7 1,378 1,422 2,117 -141.5
Operating Margin 13.04% 13.74% 33.16% 33.32% 30.37% -5.83%
Earnings before Tax (EBT) 1 298.7 328.8 1,356 1,384 2,065 -185.6
Net income 1 207.8 202.5 675.4 721 970.8 -234
Net margin 10.44% 8.39% 16.25% 16.89% 13.93% -9.64%
EPS 2 0.4046 0.3946 1.318 1.364 1.821 -0.4550
Free Cash Flow 1 25.78 -82.95 653.2 498.1 1,401 -786.6
FCF margin 1.3% -3.44% 15.72% 11.67% 20.1% -32.4%
FCF Conversion (EBITDA) 7.48% - 43.28% 32.76% 61.44% -
FCF Conversion (Net income) 12.41% - 96.72% 69.09% 144.28% -
Dividend per Share 2 0.0650 0.0650 0.2000 0.0650 0.6000 -
Announcement Date 3/21/19 4/28/20 4/27/21 4/29/22 3/22/23 3/22/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 21.8 - 257 - -
Net Cash position 1 129 - 1,041 - 2,609 1,040
Leverage (Debt/EBITDA) - 0.0485 x - 0.1691 x - -
Free Cash Flow 1 25.8 -83 653 498 1,401 -787
ROE (net income / shareholders' equity) 10.9% 10.7% 34.7% 28.9% 31.5% -3.27%
ROA (Net income/ Total Assets) 5.21% 5.75% 17.8% 15.8% 16.8% -1.13%
Assets 1 3,985 3,521 3,796 4,565 5,785 20,669
Book Value Per Share 2 4.230 4.580 6.110 7.300 9.360 8.110
Cash Flow per Share 2 0.9500 0.8600 4.180 1.170 6.760 3.170
Capex 1 124 140 258 226 428 331
Capex / Sales 6.23% 5.81% 6.2% 5.29% 6.14% 13.63%
Announcement Date 3/21/19 4/28/20 4/27/21 4/29/22 3/22/23 3/22/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD Stock Shanghai Kehua Bio-Engineering Co.,Ltd
-35.76% 519M
BIOMÉRIEUX Stock bioMérieux
+0.80% 12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-7.57% 7.84B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+1.63% 5.5B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.93% 4.61B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+7.12% 4.61B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-48.74% 3.4B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+9.21% 2.66B
VITROLIFE AB Stock Vitrolife AB
-14.59% 2.08B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+3.00% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 002022 Stock
  4. Financials Shanghai Kehua Bio-Engineering Co.,Ltd